Patents for A61P 33 - Antiparasitic agents (21,787) |
---|
10/09/2002 | EP1246624A2 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
10/09/2002 | CN1373771A Vaccine |
10/09/2002 | CN1373115A Synthesizing process for phenylhydroxy acetic acid and its salts, and application thereof in treating malaria |
10/09/2002 | CN1092059C Medicine for treating toxoplasmosis |
10/09/2002 | CN1092048C Compound piperaquine tablet |
10/09/2002 | CN1092030C Method for extracting sulfur-contg. component part from galic and method for preparation of oil and fat contg. same |
10/08/2002 | US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
10/08/2002 | US6461607 Probiotic, lactic acid-producing bacteria and uses thereof |
10/08/2002 | CA2252982C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
10/03/2002 | WO2002077074A1 Compounds for a controlled release of active compounds |
10/03/2002 | WO2002077008A1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same |
10/03/2002 | WO2002077005A1 Pesticidal spinosyn derivatives |
10/03/2002 | WO2002077004A1 Synthetic derivatives of 21-butenyl and related spinosyns |
10/03/2002 | WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors |
10/03/2002 | WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
10/03/2002 | WO2002076500A1 Vaccine for the treatment of tubercolosis and other intracellular infections diseases |
10/03/2002 | WO2002076485A2 Vaccine for modulating between t1 and t2 immune responses |
10/03/2002 | WO2002076451A1 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases |
10/03/2002 | WO2002057248A3 Inhibitors of cruzipain and other cysteine proteases |
10/03/2002 | WO2001071004A3 Proteases |
10/03/2002 | US20020143055 Administering an effective amount of propionoyloxymethyl propionate, butyroyloxymethyl butyrate, or mixtures for therapy of illness |
10/03/2002 | US20020143043 For therapy and prophylaxis of rheumatoid arthritis, or of allergic disorders, asthma, inflammation; inhibitors of the adhesion and migration of leucocytes and/or antagonists of adhesion receptor VLA-4 belonging to the integrins group |
10/03/2002 | US20020143018 For therapy of animals infected with parasites that cause abortigenic or neurologic diseases, for therapy of parasitic protozoa such as coccidia that cause abortigenic or neurologic diseases of mammals |
10/03/2002 | US20020142972 Antiparasitic formulation |
10/03/2002 | US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine |
10/03/2002 | US20020142023 Insecticide, miticide |
10/03/2002 | US20020142001 DNA immunization against Chlaymdia infection |
10/03/2002 | US20020141987 Fish serine proteinases and their pharmaceutical and cosmetic use |
10/03/2002 | CA2441809A1 Lipsomal vaccines comprising dilipopetides for modulating t1 and t2 immune responses |
10/03/2002 | CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
10/02/2002 | EP1245229A2 Methods and compositions for inhibition of angiogenesis |
10/02/2002 | EP1244790A2 Nucleic acids encoding polypeptides having chips activity |
10/02/2002 | EP1244684A1 Cryptosporidium sporozoite antigens |
10/02/2002 | EP1244683A1 21 human secreted proteins |
10/02/2002 | EP1244658A2 Azolyl-alkyl azole derivatives, a method for their production and their use as pesticides |
10/02/2002 | EP1244624A1 Anthracene derivatives as anti-cancer agents |
10/02/2002 | EP1244621A1 Nitrile derivatives as cathepsin k inhibitors |
10/02/2002 | EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors |
10/02/2002 | EP1244619A1 Pyrrolidines which inhibit camp-specific pde |
10/02/2002 | EP1244436A2 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis |
10/02/2002 | EP1244359A1 Combination of n-phenyl-n'-benzoyl urea derivative and nectin compounds for parasite control |
10/02/2002 | EP0966285B1 Use of (+)mefloquine for the treatment of malaria |
10/02/2002 | EP0896532B1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals |
10/02/2002 | EP0817624B1 Inhibitors of metazoan parasite proteases |
10/02/2002 | DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution |
10/02/2002 | CN1372569A Keratinocyte growth factor-2 |
10/02/2002 | CN1372568A Vaccin |
10/02/2002 | CN1372539A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
10/02/2002 | CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
10/02/2002 | CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease |
10/02/2002 | CN1372462A Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system |
10/02/2002 | CN1371708A Medicine coposition for treating hydatid disease |
10/02/2002 | CN1371689A New pharmaceutical usage of primaquine phosphate |
10/01/2002 | US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated |
10/01/2002 | US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
10/01/2002 | US6458363 Method to produce inactivated w/o emulsion adjuvated vaccines |
10/01/2002 | CA2145411C Viscous liquid xylitol compositions and process for preparing the same |
10/01/2002 | CA2065104C Erucyl, brassidyl and nervonyl derivatives |
09/26/2002 | WO2002074939A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells |
09/26/2002 | WO2002074913A2 Nucleic acid-associated proteins |
09/26/2002 | WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders |
09/26/2002 | WO2002074314A1 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives |
09/26/2002 | WO2002074313A1 Drugs containing reduced vitamin b¿2? |
09/26/2002 | WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
09/26/2002 | WO2002024685A8 Indole derivatives and their use as antifungal and/or antiparasitic agents |
09/26/2002 | WO2002024220A3 Vaccine comprising heat stress proteins from herbaceous plants |
09/26/2002 | WO2001090159B1 Compositions and methods for delivery of a molecule into a cell |
09/26/2002 | WO2001083775A3 Proteases |
09/26/2002 | WO2001032156A3 Methods for treating fibroproliferative diseases |
09/26/2002 | US20020137781 Pesticides |
09/26/2002 | US20020137714 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
09/26/2002 | CA2460779A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells |
09/26/2002 | CA2440391A1 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives |
09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
09/26/2002 | CA2439757A1 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells |
09/25/2002 | EP1243264A2 Inhibition of nitric oxide production by retinoic acid |
09/25/2002 | EP1243256A1 Vaccines absorbable by the transmucosal way |
09/25/2002 | EP1242579A2 Th1 specific cd4 t cell lines and method for inducing them ex vivo |
09/25/2002 | EP1242438A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
09/25/2002 | EP1242415A1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
09/25/2002 | EP1242414A1 Pyrazolyl benzyl ethers |
09/25/2002 | EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
09/25/2002 | EP1242371A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
09/25/2002 | EP1242365A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
09/25/2002 | EP1242104A2 Process of obtaining thylakoids from plants, pure thylakoids and use thereof |
09/25/2002 | EP1241943A1 Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same |
09/25/2002 | EP0986390B1 Pharmaceutical compositions containing cinchonine dichlorhydrate |
09/25/2002 | EP0938306B1 Antimalarial compositions containing cis-fused cyclopenteno-1,2,4-trioxane derivatives |
09/25/2002 | EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
09/25/2002 | EP0746312B1 Guanylhydrazones for treating inflammatory conditions |
09/25/2002 | CN1371390A Human G-protein coupled receptor |
09/25/2002 | CN1091369C Ointment for treating face mite disease |
09/24/2002 | WO2001072289A2 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
09/24/2002 | US6455508 Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides |
09/24/2002 | US6455504 Pesticidal macrolides |
09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
09/24/2002 | US6455039 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (mif) gene selected from dirofilaria immitis mif gene and onchocerca volvulus mif gene |
09/24/2002 | CA2404322A1 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
09/24/2002 | CA2260914C Parasiticidal pyrazoles |
09/20/2002 | WO2001070692A2 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |